The recent plunging stock prices and escalating regulatory threats facing Sarepta Therapeutics underscore a sobering truth: the path of gene therapy is fraught with peril—not just for patients, but for the industry and investors alike. Once hailed as groundbreaking, Elevidys—a gene therapy designed to combat Duchenne muscular dystrophy—now teeters on the brink of extinction due
Business
PepsiCo’s recent quarterly report suggests a company teetering on the brink of strategic revaluation, yet it’s hard to ignore the underlying fragility. The firm’s headline figures—beating analyst expectations on earnings per share and revenue—mask a deeper malaise: declining volumes in North American markets and a sluggish demand for core products. While executives celebrate slight improvements
In recent years, we have witnessed an alluring narrative that casts elite athletes like Patrick Mahomes as modern-day entrepreneurs capable of transcending their athletic exploits. The story of Mahomes diving into coffee investments, particularly with Throne Sport Coffee, appears to reinforce this myth. Yet, this romanticization often obscures the deeper, more troubling implications: Are these
The debut of Warner Bros.’ latest Superman film under the creative stewardship of James Gunn and Peter Safran marks more than just a box office event—it signifies a pivotal shift in how the iconic hero is positioned in modern cinema. The impressive $22.5 million in preview screenings signals a robust response from audiences, yet it
In recent years, the sports industry has transformed from mere entertainment to a lucrative hedge and asset class for the ultra-wealthy. The year 2025 exemplifies this shift, as blockbuster deals dominate headlines. Mark Walter’s record-breaking $10 billion acquisition of a majority stake in the Los Angeles Lakers not only symbolizes the industry’s escalating valuation but
In recent years, the valuation of professional sports teams has soared to unprecedented heights, transforming franchises into nearly untouchable assets for everyday investors. Eli Manning’s admission that he was priced out of acquiring a 1% stake in the New York Giants offers a stark reflection of this reality. While this might seem like a case
In recent comments, President Donald Trump signaled a move that could radically reshape the American pharmaceutical industry: the imposition of tariffs up to 200% on imported drugs. While their intention might be rooted in economic nationalism—aiming to stimulate domestic manufacturing—the approach is fundamentally flawed. Heavy tariffs have long been associated with protectionist policies that can
Apple’s bold venture into the cinematic universe with “F1: The Movie” signifies more than just a hit at the box office—it reveals a strategic shift that challenges conventional metrics of film profitability and industry focus. While traditional studios chase blockbuster revenues through massive global releases, Apple’s approach underscores an entrepreneurial mindset rooted in calculated risk,
As recent years have shown, the restaurant industry is navigating stormy economic waters. Consumers have become increasingly cautious with their spending, forcing brands to rethink their strategies fundamentally. Loyalty programs have surged to the forefront as a crucial tool—viewed not just as a marketing tactic but as a lifeline. However, this reliance raises questions about
In a society obsessed with novelty, the recent Summer Fancy Food Show revealed that culinary trends are more than fleeting fads—they are indicators of a deeper cultural shift. Chefs and entrepreneurs alike are pushing boundaries, transforming simple condiments into sophisticated elements of gourmet refinement and lifestyle branding. But beneath this surface of innovation lies a